Scientists have detailed a mechanism by which Engrailed-2 (EN2) may provide a mode of communication between prostate cancer cells and the surrounding stroma.
2 April 2019 Comment
28 March 2019 News
Clarus Therapeutics has announced that the US Food and Drug Administration (FDA) has approved its oral testosterone undecanoate (TU) Jatenzo for testosterone replacement therapy.
20 March 2019 Comment
On the back of positive results from their Phase III trial of darolutamide in men with high-risk nonmetastatic castration-resistant prostate cancer (nmCRPC), Bayer and Orion have filed for approval to...
14 February 2019 Analysis
Erectile dysfunction affects around 50% of men between 40 and 70 years old. Futura Medical is currently developing a topical gel product, named MED2005, as a new therapeutic approach for...